HAE
Haemonetics Corporation
stockNYSE
haemonetics is the blood management company. our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. our mission we believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. we seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn't need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 119.93 | 2026-11-06 | +2.30% | -1.675 |
| 1M | 121.72 | 2026-10-13 | +0.80% | 0.404 |
| 3M | 90.38 | 2026-08-13 | +35.75% | 0.063 |
| 6M | 57.01 | 2026-05-13 | +115.21% | 0.088 |
| 1Y | 73.91 | 2025-11-13 | +66.00% | 0.241 |
| 2Y | 91.78 | 2024-11-13 | +33.68% | — |
| 5Y | 59.96 | 2021-11-12 | +104.62% | 0.697 |
Haemonetics Corporation (NYSE:HAE) stock price today is $122.69, and today's volume is 194,128. HAE is down 0.016% today. The 30 day average volume is 765,872. HAE market cap is $5.59B with 45.54M shares outstanding.